Brokerages Set Tenet Healthcare Corporation (NYSE:THC) Target Price at $244.16

Shares of Tenet Healthcare Corporation (NYSE:THC) have received an average recommendation of “Moderate Buy” from the twenty-two analysts that are presently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $244.1579.

A number of equities analysts have commented on the stock. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Wall Street Zen downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Robert W. Baird dropped their price target on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Finally, Stephens cut their price objective on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a report on Monday, May 4th.

Insider Buying and Selling at Tenet Healthcare

In related news, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the transaction, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at $6,983,853.13. This represents a 18.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 15,138 shares of company stock worth $3,065,789 over the last ninety days. Insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of THC. Triumph Capital Management bought a new position in Tenet Healthcare during the 3rd quarter worth approximately $25,000. Activest Wealth Management bought a new stake in Tenet Healthcare in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC bought a new position in shares of Tenet Healthcare in the fourth quarter worth approximately $29,000. Canada Pension Plan Investment Board purchased a new position in shares of Tenet Healthcare in the second quarter worth $35,000. Finally, Meeder Asset Management Inc. raised its holdings in Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after buying an additional 114 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $162.20 on Wednesday. The stock’s 50-day simple moving average is $186.17 and its two-hundred day simple moving average is $200.80. Tenet Healthcare has a twelve month low of $146.60 and a twelve month high of $247.21. The firm has a market capitalization of $13.97 billion, a P/E ratio of 8.43, a P/E/G ratio of 1.33 and a beta of 1.28. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.Tenet Healthcare’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities analysts anticipate that Tenet Healthcare will post 17.61 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.